Company: SWKH
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001628280-25-040420
Chunk: 51

Company: SWK Holdings Corp
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 51
---
 11.0%935 1,826 Biotricity, Inc.First lien02/15/2714,446 14,994 11.5%669 1,344 CDMO ManufacturerFirst lien09/13/275,000 5,442 13.3%199 394 eTon Pharmaceuticals, Inc.First lien12/17/2730,000 29,389 11.8%1,133 2,235 Journey Medical CorporationFirst lien12/27/2725,000 25,178 12.8%916 1,817 MedMinder Systems, Inc.First lien08/18/2822,500 22,912 12.3%818 1,592 MolecuLight, Inc.(7)First lien12/29/27— — 12.8%— 27 Nicoya Lifesciences, Inc.First lien11/30/268,500 8,746 12.8%316 564 NeoLight, LLCFirst lien05/15/275,362 5,702 13.5%214 457 Shield Therapeutics, PlcFirst lien09/28/2820,000 19,905 14.3%848 1,668 SKNVFirst lien11/15/2815,997 16,396 14.0%498 992 Triple RingFirst lien12/06/288,000 8,007 12.0%282 560 ImpediMedFirst lien02/05/3010,000 9,717 13.8%391 626 

Gain (Loss) RecognizedMarketable InvestmentsNumber of SharesFunded AmountGAAP BalanceQ2 2025Year-to-DateSecured Royalty Financing (Marketable Investment) (2), (3)N/A$3,000 $6 $— $— AOTI Common Stock (5)402,634 N/A498 37 (68)Elutia, Inc (8)50,000 N/A$99 $17 $17 

27

Privately Held SharesNumber of SharesEpica International, Inc25,000 Sincerus Pharmaceuticals, Inc26,575 MolecuLight, Inc250,000 

Change in Fair Value Warrants to Purchase StockNumber of SharesExercise Price per ShareGAAP BalanceQ